1. Home
  2. GKOS vs KMPR Comparison

GKOS vs KMPR Comparison

Compare GKOS & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • KMPR
  • Stock Information
  • Founded
  • GKOS 1998
  • KMPR 1990
  • Country
  • GKOS United States
  • KMPR United States
  • Employees
  • GKOS 995
  • KMPR N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • KMPR Property-Casualty Insurers
  • Sector
  • GKOS Health Care
  • KMPR Finance
  • Exchange
  • GKOS Nasdaq
  • KMPR Nasdaq
  • Market Cap
  • GKOS 5.1B
  • KMPR 4.2B
  • IPO Year
  • GKOS 2015
  • KMPR N/A
  • Fundamental
  • Price
  • GKOS $90.26
  • KMPR $56.71
  • Analyst Decision
  • GKOS Strong Buy
  • KMPR Strong Buy
  • Analyst Count
  • GKOS 13
  • KMPR 4
  • Target Price
  • GKOS $155.00
  • KMPR $81.00
  • AVG Volume (30 Days)
  • GKOS 1.0M
  • KMPR 615.8K
  • Earning Date
  • GKOS 04-30-2025
  • KMPR 04-30-2025
  • Dividend Yield
  • GKOS N/A
  • KMPR 2.26%
  • EPS Growth
  • GKOS N/A
  • KMPR N/A
  • EPS
  • GKOS N/A
  • KMPR 4.91
  • Revenue
  • GKOS $383,481,000.00
  • KMPR $4,639,200,000.00
  • Revenue This Year
  • GKOS $27.84
  • KMPR $9.33
  • Revenue Next Year
  • GKOS $27.99
  • KMPR $11.79
  • P/E Ratio
  • GKOS N/A
  • KMPR $11.55
  • Revenue Growth
  • GKOS 21.85
  • KMPR N/A
  • 52 Week Low
  • GKOS $77.91
  • KMPR $53.57
  • 52 Week High
  • GKOS $163.71
  • KMPR $73.01
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 41.57
  • KMPR 34.08
  • Support Level
  • GKOS $86.16
  • KMPR $56.11
  • Resistance Level
  • GKOS $94.55
  • KMPR $59.27
  • Average True Range (ATR)
  • GKOS 6.54
  • KMPR 2.69
  • MACD
  • GKOS 1.11
  • KMPR -0.51
  • Stochastic Oscillator
  • GKOS 54.51
  • KMPR 21.70

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About KMPR Kemper Corporation

Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.

Share on Social Networks: